In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

AUTOR(ES)

Wexler, H M

RESUMO

The antimicrobial activity of trovafloxacin for 557 strains of anaerobic bacteria was determined by the National Committee for Clinical Laboratory Standards-approved Wadsworth agar dilution technique. The species tested included Bacteroides fragilis (n = 91), other members of the B. fragilis group (n = 130), Campylobacter gracilis (n = 15), other Bacteroides spp. (n = 16), Prevotella spp. (n = 49), Porphyromonas spp. (n = 15), Fusobacterium spp. (n = 62), Bilophila wadsworthia (n = 24), Sutterella wadsworthensis (n = 21), Clostridium spp. (n = 61), Peptostreptococcus spp. (n = 38), and gram-positive non-spore-forming rods (n = 35). Trovafloxacin inhibited all strains of B. fragilis at < or = 0.5 microgram/ml, 99% of other B. fragilis group species at < or = 2 micrograms/ml, and 96% of all anaerobes tested at < or = 2 micrograms/ml.

Documentos Relacionados

• Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.
• In vitro activities of three of the newer quinolones against anaerobic bacteria.
• In Vitro Activities of Faropenem against 579 Strains of Anaerobic Bacteria
• Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.
• In vitro activity of cefbuperazone against anaerobic bacteria.